新賽股份(600540.SH)非公開發行A股申請獲師市國資委批覆
格隆匯9月4日丨新賽股份(600540.SH)公佈,公司於2020年9月4日收到第五師雙河市國有資產監督管理委員會《關於同意新疆賽裏木現代農業股份有限公司非公開發行A股股票的批覆》,同意新疆賽裏木現代農業股份有限公司非公開發行A股股票方案。根據中國證監會《上市公司證券發行管理辦法》的規定,發行價格應不低於定價基準日前20個交易日公司股票交易均價的80%,本次非公開發行的定價基準日為本次非公開發行的發行期首日。
同意新疆賽裏木現代農業股份有限公司向特定對象非公開增發新股的額度不超過1.24億股(含),募集資金6.085億元(含發行費用)。最終的發行數量以確定的發行價格和中國證監會的核準結果為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.